AI-Driven Assessment of Fibrotic and Vascular Changes Correlates with Patient Outcomes in Idiopathic Pulmonary Fibrosis - Takeaways - MDSpire

AI-Driven Assessment of Fibrotic and Vascular Changes Correlates with Patient Outcomes in Idiopathic Pulmonary Fibrosis

  • By

  • Julien Guiot

  • Jonne Engelberts

  • Monique Henket

  • Benoit Ernst

  • Quentin Maloir

  • Renaud Louis

  • David A. Lynch

  • Stephen M. Humphries

  • Jean-Paul Charbonnier

  • October 24, 2025

  • 0 min

Share

  • 1

    Idiopathic pulmonary fibrosis (IPF) is a severe progressive interstitial lung disease with high morbidity and mortality despite available anti-fibrotic therapies.

  • 2

    AI-driven imaging biomarkers can improve the assessment of disease severity in IPF, addressing limitations of traditional pulmonary function tests and visual imaging.

  • 3

    The study utilized a multicentric cohort from the OSIC consortium, analyzing CT scans of 319 IPF patients to evaluate vascular and interstitial abnormalities.

  • 4

    Quantitative analysis of CT scans using AI can help identify pulmonary hypertension in IPF patients, which is associated with increased morbidity and mortality.

  • 5

    Survival analysis indicated that the extent of interstitial lung abnormalities significantly correlates with patient outcomes in those with idiopathic pulmonary fibrosis.

Original Source(s)

AI-Driven Assessment of Fibrotic and Vascular Changes Correlates with Patient Outcomes in Idiopathic Pulmonary Fibrosis

  • by Julien Guiot, Jonne Engelberts, Monique Henket, Benoit Ernst, Quentin Maloir, Renaud Louis, David A. Lynch, Stephen M. Humphries, Jean-Paul Charbonnier

  • October 24, 2025

Related Content

NPs Top US Jobs List Again

The nurse practitioner profession claims the No. 1 spot across three categories in the U.S. News & World Report 2026 Best Jobs rankings for the third consecutive year.

AI Scribes: Efficiency for Whom?

Unresolved safety, privacy, and regulatory concerns may limit benefits of AI scribes for physicians and patients.

Evaluating Health-Related Quality of Life in Interstitial Lung Disease Patients With and Without Lung Transplantation Using the GR-Scale